GeneDx Holdings Corp. Class A Common Stock Profile
About
GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.
Info & Links
CEO
Katherine Stueland
Headquarters
333 Ludlow Street, North Tower, 6th Floor Stamford, CT 06902, UNITED STATES
GeneDx Holdings Corp. Class A Common Stock Statistics
Valuation Measures
Market Capitalization2
2.50B
Enterprise Value
2.46B
Enterprise Value/EBITDA(ttm)
-1.96K
Price to Earnings Ratio(ttm)
338.60
Price to Sales(ttm)
9.14
Price to Book(mrq)
13.65
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
63.07%
Operating Margin(ttm)
2.20%
Profit Margin(ttm)
-19.73%
Return on Equity(ttm)
3.33%
Return on Invested Capital(ttm)
-21.06%
Return on Assets(ttm)
1.69%
Income Statement
Revenue(ttm)
305.45M
Revenue Per Share(ttm)
10.88
Gross Profit(ttm)
194.40M
EBITDA(ttm)3
-1.26M
Net Income Available to Common(ttm)
-52.29M
Diluted EPS(ttm)
-1.96
Share Statistics
Beta (5Y Monthly)
2.01
52-Week Change
813.67%
S&P 500 52-Week Change
8.82%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
28.07M
Dividend Yield
0.00%
Float4
19.97M
% Held by Insiders
27.30%
% Held by Institutions
61.72%
Balance Sheet
Total Cash(mrq)
141.19M
Total Cash Per Share(mrq)
5.03
Total Debt(mrq)
51.91M
Total Debt/Equity(mrq)
21.17%
Current Ratio(mrq)
3.61%
Quick Ratio(mrq)
2.27%
Book Value Per Share(mrq)
8.75
Cash Flow
Operating Cash Flow Per Share(ytd)
-1.06
Free Cash Flow(ytd)
-33.99M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.